SecSonar.com

Harrow Health, Inc. (HROW)

Harrow Health, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Harrow Health, Inc. (HROW) is a Drug Manufacturers - Specialty & Generic company based in US with a market capitalization of $1.3B. Revenue grew 36.4% year-over-year and the company generated $43M in free cash flow. This page tracks HROW's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 382 employees · IPO Sep 28, 2007

Valuation

Valuation & price

$31.21 · as of May 17, 2026 · -43.0% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

24.84

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$53.99$41.51$29.03Jul 25Dec 25Jul 26Jul 7, 25$31.36Jul 9, 25$31.66Jul 11, 25$34.93Jul 15, 25$34.37Jul 17, 25$36.14Jul 21, 25$37.08Jul 23, 25$36.95Jul 25, 25$36.19Jul 29, 25$34.53Jul 31, 25$31.76Aug 4, 25$33.42Aug 6, 25$33.02Aug 11, 25$33.74Aug 13, 25$36.50Aug 15, 25$38.82Aug 19, 25$38.23Aug 21, 25$38.16Aug 25, 25$37.36Aug 27, 25$38.79Aug 29, 25$39.00Sep 3, 25$37.34Sep 5, 25$36.99Sep 9, 25$39.30Sep 11, 25$39.45Sep 16, 25$42.89Sep 18, 25$45.38Sep 22, 25$46.09Sep 24, 25$47.88Sep 26, 25$47.10Sep 30, 25$48.18Oct 2, 25$47.73Oct 6, 25$42.16Oct 8, 25$39.74Oct 10, 25$37.48Oct 14, 25$39.36Oct 16, 25$37.92Oct 21, 25$40.82Oct 23, 25$39.04Oct 27, 25$38.24Oct 29, 25$36.78Oct 31, 25$37.77Nov 4, 25$35.31Nov 6, 25$34.44Nov 10, 25$34.14Nov 12, 25$38.44Nov 14, 25$40.79Nov 18, 25$39.73Nov 20, 25$37.66Nov 25, 25$41.02Nov 28, 25$41.78Dec 2, 25$40.17Dec 4, 25$46.77Dec 8, 25$47.47Dec 10, 25$50.20Dec 12, 25$47.06Dec 16, 25$44.77Dec 18, 25$44.56Dec 22, 25$49.38Dec 24, 25$50.16Dec 29, 25$50.76Jan 2, 26$49.91Jan 6, 26$53.50Jan 8, 26$51.04Jan 12, 26$47.84Jan 14, 26$48.16Jan 16, 26$47.90Jan 21, 26$47.12Jan 23, 26$44.47Jan 27, 26$42.98Jan 29, 26$41.93Feb 2, 26$44.90Feb 4, 26$47.20Feb 9, 26$47.46Feb 11, 26$48.66Feb 13, 26$47.69Feb 18, 26$49.87Feb 20, 26$52.00Feb 24, 26$52.78Feb 26, 26$53.99Mar 2, 26$53.59Mar 4, 26$39.22Mar 6, 26$36.35Mar 10, 26$36.08Mar 12, 26$35.56Mar 17, 26$35.23Mar 19, 26$34.41Mar 23, 26$34.00Mar 25, 26$36.35Mar 27, 26$33.83Mar 31, 26$35.26Apr 2, 26$35.31Apr 7, 26$35.43Apr 9, 26$37.29Apr 13, 26$37.10Apr 15, 26$38.79Apr 17, 26$41.50Apr 22, 26$39.14Apr 24, 26$39.70Apr 28, 26$40.48Apr 30, 26$40.53May 4, 26$40.20May 6, 26$40.27May 8, 26$38.23May 12, 26$29.03May 14, 26$30.86May 18, 26$30.90May 20, 26$30.86May 22, 26$33.00May 28, 26$35.39Jun 1, 26$34.11Jun 3, 26$33.32Jun 5, 26$33.19Jun 9, 26$33.46Jun 11, 26$37.65Jun 15, 26$38.93Jun 17, 26$41.94Jun 22, 26$42.41Jun 24, 26$42.68Jun 26, 26$42.07Jul 2, 26$42.25
$29.0352-week range$54.80
Loading valuation history…

Fundamentals

Key fundamentals

$1.3B

Market cap

36.4%

Revenue growth (YoY)

75.0%

Gross margin

$43M

Free cash flow (USD)

$179M

Net debt

3.1%

Share dilution

0/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$19.9MFY 2017$26.8MFY 2018$41.4MFY 2019$51.2MFY 2020$48.9MFY 2021$72.5MFY 2022$88.6MFY 2023$130.2MFY 2024$199.6MFY 2025$272.3M
$19.9M$272.3M

Free cash flow by year

2016 → 2025

FY 2016$-18.4MFY 2017$-9.9MFY 2018$-1.5MFY 2019$-887.0KFY 2020$-2.1MFY 2021$-23.4MFY 2022$-6.1MFY 2023$-148.7MFY 2024$-60.9MFY 2025$43.0M
-$18.4M$43M

Gross margin by year

2021 → 2025

FY 202174.9%FY 202271.3%FY 202369.5%FY 202475.3%FY 202575.0%
74.9%75.0%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

4

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 11, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventAnnual Meeting ResultsJun 22, 2026Filing
  • 8-K eventCorporate Presentation IssuedJun 3, 2026Filing
  • Insider buyInsider Buy $31KSILVERNAIL LAUREN P · Director · $31KMay 19, 2026Filing
  • Insider buyInsider Buy $31KGraves Adrienne L · Director · $31.1KMay 19, 2026Filing
  • Insider buyInsider Buy $105KBOLL ANDREW R. · PRESIDENT AND CFO · $104.7KMay 15, 2026Filing
  • Insider buyInsider Buy $302KBAUM MARK L · Director, CHIEF EXECUTIVE OFFICER · $302KMay 15, 2026Filing
  • 8-K eventQuarterly Letter to StockholdersMay 11, 2026Filing
  • Quarterly report10-Q FiledMay 11, 2026Filing

Questions

Frequently asked questions

What is Harrow Health, Inc.'s market cap?

Harrow Health, Inc. (HROW) has a market capitalization of $1.3B.

What is HROW's P/E ratio?

A meaningful P/E ratio is not available for HROW — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is HROW's price-to-book (P/B) ratio?

HROW trades at 24.84 times book value per share.

Are insiders buying HROW stock?

Yes — SEC Form 4 filings show 4 open-market insider buys and 0 sells at Harrow Health, Inc. in the last 90 days.

Same arena

Related companies in Drug Manufacturers - Specialty & Generic

PAHC

Phibro Animal Health Corporation

$1.3B

EVO

Evotec SE

$1.1B

COLL

Collegium Pharmaceutical, Inc.

$1.1B

ALVO

Alvotech

$1.1B

CRON

Cronos Group Inc.

$1.1B

PRGO

Perrigo Company plc

$1.6B

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.